What is MaxCyte's net margin?

MaxCyte (MXCT) reported net margin of -121.2% in Q1 2026.

How has MaxCyte's net margin changed year-over-year?

MaxCyte's net margin decreased by 9.2% year-over-year, from -110.9% to -121.2%.

What is the long-term trend for MaxCyte's net margin?

Over 5 years (2020 to 2025), MaxCyte's net margin has grown at a 24.5% compound annual growth rate (CAGR), from -45.2% to -135.1%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

MaxCyte MXCT Net margin

Net margin at other companies

Bio-Rad LaboratoriesBIO

6.5%+3.4pp

Thermo Fisher ScientificTMO

15.2%+1.0pp

Ginkgo BioworksDNA

-215.4%+8.3pp

Rapid Micro BiosystemsRPID

-145.8%-5.0pp

PDE

Pro-Dex, Inc.PDEX

16.1%+1.5pp

RepligenRGEN

17.1%-3.7pp

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Calculated from MaxCyte’s reported figures.

net income/total revenue=-121.2%

Based on trailing twelve months.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's net margin?: MaxCyte (MXCT) reported net margin of -121.2% in Q1 2026.
How has MaxCyte's net margin changed year-over-year?: MaxCyte's net margin decreased by 9.2% year-over-year, from -110.9% to -121.2%.
What is the long-term trend for MaxCyte's net margin?: Over 5 years (2020 to 2025), MaxCyte's net margin has grown at a 24.5% compound annual growth rate (CAGR), from -45.2% to -135.1%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.